Cell based assays indicated a predominant effect of GSK3α knockdown in prostate cancer cells on cell survival, proliferation and tumor growth with only a modest or no effect of GSK3β knockdown on these cell functions. This evidence concerns the gene GSK3B and prostate carcinoma.